Development and validation of the Essen Melanoma Quality of Life Inventory (EMQoLI)

Key Points

• To develop and validate a self-report tool that assesses health-related quality of life in melanoma patients at all tumor stages.
• Created a 25-item questionnaire based on a 5-point Likert scale.
• Targeted melanoma patients for self-reporting their quality of life.
• Validated the inventory for clinical settings to ensure reliability and efficacy.
• The EMQoLI effectively identifies patients requiring psychosocial support.
• Demonstrated strong reliability as a measurement instrument for health-related quality of life.
• Applicable across various stages of melanoma.